Yangbing Zhao

14.2k citations

65 papers · 8.6k indexed · 7 hit papers · h-index 41

Impact in

Oncology top 0.1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses

Papers in

Oncology 53
- CAR-T cell therapy research 53
Immunology 32
- Immunotherapy and Immune Responses 20
- Immune Cell Function and Interaction 14
- T-cell and B-cell Immunology 7

Co-authors: Carl H. June Xiaojun Liu Steven A. Rosenberg Shuguang Jiang Jiangtao Ren Zhili Zheng Chongyun Fang Marcela V. Maus
Journals: Cancer Research (7 papers)Blood (7 papers)The Journal of Immunology (5 papers)Human Gene Therapy (4 papers)Cancer Immunology Research (4 papers)
Partner nations: United States China Japan

In The Last Decade

Yangbing Zhao

64 papers receiving 8.5k citations

Hit Papers

7 papers align trajectories log scale

Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication 2018 · 478 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Molecular Therapy
2017 Cell Reports
2016 Cancer Research
2016 Clinical Cancer Research
2015 Cancer Research
2013 Cancer Immunology Research
2013 Cancer Immunology Research

Peers

Countries citing papers authored by Yangbing Zhao

Since Specialization

Citations

This map shows the geographic impact of Yangbing Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangbing Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangbing Zhao more than expected).

Fields of papers citing papers by Yangbing Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangbing Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangbing Zhao. The network helps show where Yangbing Zhao may publish in the future.

Co-authors

The 25 scholars most cited alongside Yangbing Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yangbing Zhao Line = papers co-authored together Yangbing Zhao links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Phase I Study of CD19‐targeted 19(T2)28z1xx CAR T Cells in Adult Patients with Relapsed or Refractory Diffuse Large B‐cell Lymphoma Hematological Oncology ·M. Lia Palomba, Isabelle Rivière, Devanjan Sikder, Brigitte Sénéchal, X. Wang, Elizabeth Cathcart, Kelly Liotta, Jianling Li, Leopold Sellner, Michel Sadelain, Sharon Chen, Yangbing Zhao, J. H. Park	2023	1
2	A rational mouse model to detect on-target, off-tumor CAR T cell toxicity JCI Insight ·Mauro Castellarin, Caroline Sands, Tong Da, John Scholler, Kathleen Graham, Elizabeth L. Buza, Joseph A. Fraietta, Yangbing Zhao, Carl H. June	2020	72
3	Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication Molecular Therapy ·Christopher C. Kloss, Ji‐Hyun Lee, Aaron Zhang, Fang Chen, J. Joseph Melenhorst, Simon F. Lacey, Marcela V. Maus, Joseph A. Fraietta, Yangbing Zhao, Carl H. June Hit paper breakdown →	2018	478
4	Increasing the safety and efficacy of chimeric antigen receptor T cell therapy Protein & Cell ·Hua Li, Yangbing Zhao	2017	61
5	Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition Clinical Cancer Research ·Jiangtao Ren, Xiaojun Liu, Chongyun Fang, Shuguang Jiang, Carl H. June, Yangbing Zhao Hit paper breakdown →	2016	738
6	A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors Cancer Research ·Xiaojun Liu, Raghuveer Ranganathan, Shuguang Jiang, Chongyun Fang, Jing Sun, Soyeon Kim, Kheng Newick, Albert Lo, Carl H. June, Yangbing Zhao, Edmund K. Moon Hit paper breakdown →	2016	420
7	Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer Clinical Cancer Research ·Edmund K. Moon, Raghuveer Ranganathan, Evgeniy Eruslanov, Soyeon Kim, Kheng Newick, Shaun O’Brien, Albert Lo, Xiaojun Liu, Yangbing Zhao, Steven Μ. Albelda	2015	96
8	Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells Cancer Immunology Research ·Matthew J. Frigault, Ji‐Hyun Lee, Maria C. Basil, Carmine Carpenito, Shinichiro Motohashi, John Scholler, Omkar U. Kawalekar, Sònia Guedan, Shannon E. McGettigan, Avery D. Posey, Sonny Ang, Laurence J.N. Cooper, Jesse M. Platt, F. Brad Johnson, Chrystal M. Paulos, Yangbing Zhao, Michael Kalos, Michael C. Milone, Carl H. June	2015	233
9	Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice Cancer Research ·Xiaojun Liu, Shuguang Jiang, Chongyun Fang, Shiyu Yang, Devvora Olalere, Edward Pequignot, Alexandria P. Cogdill, Na Li, Melissa Ramones, Brian Granda, Li Zhou, Andreas Loew, Regina M. Young, Carl H. June, Yangbing Zhao Hit paper breakdown →	2015	425
10	Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma Cancer Immunology Research ·Nathan Singh, Xiaojun Liu, Jessica Hulitt, Shuguang Jiang, Carl H. June, Stephan A. Grupp, David M. Barrett, Yangbing Zhao	2014	65
11	Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies Cancer Immunology Research ·Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus, Drew A. Torigian, Michael C. Soulen, Gabriela Plesa, Anne Chew, Yangbing Zhao, Bruce L. Levine, Steven Μ. Albelda, Michael Kalos, Carl H. June Hit paper breakdown →	2013	693
12	Regimen-Specific Effects of RNA-Modified Chimeric Antigen Receptor T Cells in Mice with Advanced Leukemia Human Gene Therapy ·David M. Barrett, Xiaojun Liu, Shuguang Jiang, Carl H. June, Stephan A. Grupp, Yangbing Zhao	2013	99
13	Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells Human Gene Therapy ·David M. Barrett, Yangbing Zhao, Xiaojun Liu, Shuguang Jiang, Carmine Carpenito, Michael Kalos, Richard G. Carroll, Carl H. June, Stephan A. Grupp	2011	182
14	A High Molecular Weight Melanoma-Associated Antigen–Specific Chimeric Antigen Receptor Redirects Lymphocytes to Target Human Melanomas Cancer Research ·William R. Burns, Yangbing Zhao, Timothy L. Frankel, Christian S. Hinrichs, Zhili Zheng, Hui Xu, Steven A. Feldman, Soldano Ferrone, Steven A. Rosenberg, Richard A. Morgan	2010	63
15	Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor Cancer Research ·Yangbing Zhao, Edmund K. Moon, Carmine Carpenito, Chrystal M. Paulos, Xiaojun Liu, Andrea Brennan, Anne Chew, Richard G. Carroll, John Scholler, Bruce L. Levine, Steven Μ. Albelda, Carl H. June	2010	366
16	Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice Journal of Clinical Investigation ·Dhanalakshmi Chinnasamy, Zhiya Yu, Marc R. Theoret, Yangbing Zhao, Rajeev Shrimali, Richard A. Morgan, Steven A. Feldman, Nicholas P. Restifo, Steven A. Rosenberg	2010	205
17	Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity Gene Therapy ·P. Peng, Cyrille J. Cohen, Shuzhen Yang, Ching‐Sheng Hsu, Simon Jones, Yangbing Zhao, Zhili Zheng, Steven A. Rosenberg, Richard A. Morgan	2009	79
18	Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions The Journal of Immunology ·Paul F. Robbins, Yong F. Li, Mona El‐Gamil, Yangbing Zhao, Jennifer A. Wargo, Zhili Zheng, Hui Xu, Richard A. Morgan, Steven A. Feldman, Laura A. Johnson, Alan Bennett, Steven M. Dunn, Tara Mahon, Bent K. Jakobsen, Steven A. Rosenberg	2008	252
19	High-Affinity TCRs Generated by Phage Display Provide CD4+ T Cells with the Ability to Recognize and Kill Tumor Cell Lines The Journal of Immunology ·Yangbing Zhao, Alan Bennett, Zhili Zheng, Qiong J. Wang, Paul F. Robbins, Lawrence Yu, Yi Li, Peter Molloy, Steven M. Dunn, Bent K. Jakobsen, Steven A. Rosenberg, Richard A. Morgan	2007	164
20	Recognition of Fresh Human Tumor by Human Peripheral Blood Lymphocytes Transduced with a Bicistronic Retroviral Vector Encoding a Murine Anti-p53 TCR The Journal of Immunology ·Cyrille J. Cohen, Zhili Zheng, Regina B. Bray, Yangbing Zhao, Linda A. Sherman, Steven A. Rosenberg, Richard A. Morgan	2005	94

About Yangbing Zhao

Yangbing Zhao is a scholar working on Oncology, Immunology, Genetics, Business and International Management and Molecular Biology, having authored 65 papers that have together received 8.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (53 papers), Virus-based gene therapy research (25 papers), Immunotherapy and Immune Responses (20 papers), Immune Cell Function and Interaction (14 papers), Viral Infectious Diseases and Gene Expression in Insects (11 papers), CRISPR and Genetic Engineering (8 papers), T-cell and B-cell Immunology (7 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Oncology (7.4k citations), Immunology (3.6k citations), Genetics (2.8k citations), Biomedical Engineering (2.2k citations) and Molecular Biology (3.2k citations). Yangbing Zhao has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Carl H. June, Xiaojun Liu, Steven A. Rosenberg, Shuguang Jiang, Jiangtao Ren, Zhili Zheng, Chongyun Fang, Marcela V. Maus, Bruce L. Levine and Michael Kalos. Their work appears in journals such as Cancer Research, Blood, The Journal of Immunology, Human Gene Therapy and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact